DGX-QUEST DIAGNOSTICS INC

Quest Diagnostics Achieves Strong Performance with 28.4% Share Growth and Zacks Rank #2 Amidst Competitive Market Challenges

Member Only Article

Wednesday

19 February, 2025

Quest Diagnostics has showcased remarkable resilience in a competitive landscape, achieving a 28.4% share growth and earning a Zacks Rank of #2. With a solid earnings yield and a history of exceeding expectations, can this healthcare leader continue to thrive amidst market challenges?

article image for DGX

Article Impact Score

0
50
100
Under­perform
Bear­ish
Neu­tral
Bull­ish
Out­perform
0
Key Takeaways
  • Loading...

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial
home-footer-logo

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.